Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 Aug;54(8):1056-7.
doi: 10.1136/gut.2004.063545.

5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!

N M Barnes  1
Affiliations
Comment

5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!

N M Barnes. Gut. 2005 Aug.

Abstract

There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.

PubMed Disclaimer

Comment on

References

    1. Hartz AJ, Bentler SE, Brake KA, et al. The effectiveness of citalopram for idiopathic chronic fatigue. J Clin Psychiatry 2003;64:927–35. - PubMed
    1. Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 1992;77:921–4. - PubMed
    1. McGuire J, Ross GL, Price H, et al. Biochemical markers for post-operative fatigue after major surgery. Brain Res Bull 2003;60:125–30. - PubMed
    1. Yamamoto S, Ouchi Y, Onoe H, et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. NeuroReport 2004;15:2571–4. - PubMed
    1. Cleare AJ, Messa C, Rabiner EA, et al. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 2005;57:239–46. - PubMed

Substances